AdaptHealth Corp

AdaptHealth Corp. engages in the provision of home healthcare equipment, supplies and related services. It focuses on sleep therapy equipment to individuals suffering from obstructive sleep apnea (OSA), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and HME medical devices and supplies on behalf of chronically ill patients with diabetes care, wound care, urological, ostomy, and nutritional supply needs. The company was founded in 2012 and is headquartered in Plymouth Meeting, PA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

AdaptHealth Corp reports robust revenue growth and strategic investments outlook

AdaptHealth Corp demonstrated resilience in revenue growth despite challenges, with a strong focus on patient care and financial performance. While facing short-term obstacles, the company is strategically positioned to capitalize on growth opportunities and improve margins through cost-cutting measures.

AdaptHealth Corp reports revenue growth amidst diabetes business challenges

AdaptHealth Corp's Q1 2023 performance showed revenue growth but faced challenges in the diabetes business, prompting cost-saving measures.
Despite hurdles, the company remains confident in its strategy, focusing on growth opportunities and operational efficiency to drive performance.
Management's proactive approach to cost reduction and revenue enhancement positions AdaptHealth well for future growth and financial stability.

AdaptHealth Corp posts solid Q2 results, eyes growth opportunities

AdaptHealth Corp's Q2 performance reflects strong revenue growth and improved EBITDA, driven by key product lines.
While challenges exist in the diabetes segment, the company is focused on operational enhancements and cost-saving measures.
Opportunities for growth and efficiency improvements are present, with a commitment to executing strategies and leveraging expertise.
Management's emphasis on financial processes and operational efficiency bodes well for future performance and market positioning.

AdaptHealth Corp reports record revenues, faces EBITDA challenges, eyes growth

AdaptHealth Corp's Q3 performance reflects revenue growth driven by the sleep business, with a focus on enhancing patient experience. Challenges include EBITDA shortfall due to contract delays and impairment to goodwill. The company is seizing opportunities in CGM data utilization and diversification strategies for growth.
With a strong emphasis on patient care and operational efficiency, AdaptHealth Corp is navigating challenges in revenue decline and tough comps, aiming for sustained growth. The company's strategic focus on market penetration and patient outcomes positions them for future success.

AdaptHealth Corp excels in Q4 2023, eyes growth opportunities

AdaptHealth Corp's strong performance in Q4 2023 and full-year highlights organic growth.
Challenges from GLP-1 drugs and government exposure are being addressed proactively.
Opportunities lie in projected revenue growth, market share improvement, and cost reduction.
Overall, AdaptHealth is well-positioned for continued growth and market resilience.

AdaptHealth Corp excels in Q1 2024, eyes growth and debt reduction

AdaptHealth Corp's Q1 2024 performance reflects solid financial growth, operational improvements, and strategic initiatives aimed at enhancing profitability and market position.
While challenges like managing potential risks in key segments and addressing debt obligations exist, the company's strengths in leadership, revenue diversification, and cost management provide a strong foundation for future success.
By capitalizing on growth opportunities in key business segments and markets, AdaptHealth Corp is well-positioned to achieve its financial targets, drive sustainable growth, and enhance shareholder value.

AdaptHealth Corp reports solid Q2 results and raises full-year guidance

AdaptHealth Corp's Q2 performance met expectations with a strong focus on driving growth through investments and operational improvements. Despite challenges in certain revenue segments, the company remains optimistic about future prospects.

AdaptHealth Corp reports solid Q3 performance amid operational enhancements

AdaptHealth Corp's Q3 results reflect resilience and strategic initiatives to drive growth amidst operational challenges.
The company's proactive measures to address issues in the diabetes segment and optimize other product lines position it for future success.
With a strengthened financial position and a focus on operational efficiency, AdaptHealth is poised for sustainable growth.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions, including home medical equipment, medical supplies and related services, announced today that its Board of Directors has named Crispin Teufel as Chief Executive Officer. Teufel is expected to assume the role on September 1, 2023. Crispin Teufel, 47, has served as the Chief Executive Officer of Lincare Holdings I.

AdaptHealth Appoints Crispin Teufel as New Chief Executive Officer

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that Josh Parnes, President, and Jason Clemens, CFO, will participate in a fireside chat at the RBC Global Healthcare Conference on Tuesday, May 16, 2023 at 4:05 pm ET. A live webcast and replay will be accessible through th.

AdaptHealth to Participate in RBC Global Healthcare Conference

Community Health Systems

FRANKLIN, Tenn.--(BUSINESS WIRE)--Community Health Systems, Inc. (NYSE: CYH) announced today that J. Anton Hie has joined the Company as Vice President of Investor Relations, effective May 15, 2023. Hie has more than 20 years of experience in the healthcare investment field and joins Community Health Systems from AdaptHealth Corp. (NASDAQ: AHCO) where he established the internal investor relations department and served as Vice President of Investor Relations from August 2021 through April this.

Community Health Systems Names J. Anton Hie Vice President of Investor Relations

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) a national leader in providing patient‐centered, healthcare‐at‐home solutions including home medical equipment, medical supplies, and related services, has entered into an agreement to become the capitated provider of durable home medical equipment and supplies to Humana Medicare Advantage HMO members in 33 states, plus the District of Columbia. AdaptHealth's agreement with Humana, which features a value-based pricing mode.

AdaptHealth Corp. Partners With Humana on Value-Based Care

The at-home healthcare specialist unveiled its first set of quarterly results for 2023. These missed on both the top and bottom lines.

Why AdaptHealth Stock Got Slammed Today

AdaptHealth Corp. (NASDAQ:AHCO ) Q1 2023 Earnings Conference Call May 9, 2023 8:30 AM ET Company Participants Chris Joyce - General Counsel Richard Barasch - Chairman Steve Griggs - Chief Executive Officer Josh Parnes - President Jason Clemens - Chief Financial Officer Conference Call Participants Brian Tanquilut – Jefferies Kevin Caliendo - UBS Philip Chickering - Deutsche Bank Joanna Gajuk - Bank of America Richard Close - Canaccord Operator Good day, everyone and welcome to today's AdaptHealth 1Q 2023 Earnings Release. At this time, all participants are in a listen-only mode.

AdaptHealth Corp. (AHCO) Q1 2023 Earnings Call Transcript

AdaptHealth Corp. (AHCO) came out with quarterly earnings of $0.01 per share, missing the Zacks Consensus Estimate of $0.08 per share. This compares to loss of $0.02 per share a year ago.

AdaptHealth Corp. (AHCO) Q1 Earnings and Revenues Lag Estimates

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results for the first quarter ended March 31, 2023. First Quarter Results and Highlights Net revenue was $744.6 million compared to $706.2 million in the first quarter of 2022, an increase of 5.4%, including 17.6%.

AdaptHealth Corp. Announces First Quarter 2023 Results

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions, including home medical equipment, medical supplies and related services, announced today that Stephen Griggs will step down as Chief Executive Officer by mutual agreement with the Board of Directors, effective June 30, 2023. The Board is working with a leading executive search firm to identify a new CEO and is c.

AdaptHealth Announces Stephen Griggs Will Step Down as CEO at the End of Second Quarter

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, will release its first quarter 2023 financial results before the opening of the financial markets on Tuesday, May 9, 2023. Management will host a teleconference at 8:30 a.m.

AdaptHealth Corp. Announces First Quarter 2023 Earnings Release Date and Conference Call

AHCO is a promising long-term investment due to the expected growth in the HME market, driven by demographic shifts and the rise of chronic diseases, as well as potential M&A. AHCO reported a 4Q22 miss, with revenue and EBITDA falling short of both consensus estimates and management guidance ranges.

AdaptHealth: Tough In The Near-Term But FY25 Targets Remain Intact

Compared to similar-sized companies in the industry, AdaptHealth looks to be at a much more favorable valuation to start a position. With revenues and cash flow up, the focus moving forward will be increasing the net margins.

AdaptHealth: Looks Very Attractive Right Now

Cara Therapeutics

Infinity Pharma

OptimizeRx Corp

Alpha Teknova

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month - Cara Therapeutics (NASDAQ:CARA), AdaptHealth (NASDAQ:AHCO)

Adapthealth Corp (NASDAQ:AHCO ) Q4 2022 Earnings Conference Call February 28, 2023 8:30 AM ET Company Participants Christopher Joyce - General Counsel & Secretary Stephen Griggs - CEO & Director Joshua Parnes - President & Director Jason Clemens - CFO & Principal Accounting Officer Conference Call Participants Philip Chickering - Deutsche Bank Joanna Gajuk - Bank of America Merrill Lynch Mathew Blackman - Stifel, Nicolaus & Company Operator Ladies and gentlemen, thank you for joining us this morning for the AdaptHealth Fourth Quarter Earnings Call. At this time, I would like to introduce Mr.

Adapthealth Corp (AHCO) Q4 2022 Earnings Call Transcript

Investors didn't like what they heard in the company's Q4 update.

Why AdaptHealth Stock Is Crashing Today

AdaptHealth (NASDAQ: AHCO ) stock is falling on Tuesday following the release of the company's earnings report for the fourth quarter of 2022. The bad news for AHCO stock starts with the company's earnings per share of -2 cents.

Why Is AdaptHealth (AHCO) Stock Down 22% Today?

AdaptHealth Corp. (AHCO) delivered earnings and revenue surprises of -96.77% and 0.97%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

AdaptHealth Corp. (AHCO) Lags Q4 Earnings and Revenue Estimates

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results for the fourth quarter and fiscal year ended December 31, 2022. Highlights of 2022 AdaptHealth provides needed medical equipment and supplies to approximately 3.9 million patients annually.

AdaptHealth Corp. Announces Fourth Quarter and Full-Year 2022 Results and Updates 2023 Outlook

AdaptHealth Corp. (AHCO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

AdaptHealth Corp. (AHCO) Reports Next Week: Wall Street Expects Earnings Growth

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, will release its fourth quarter and full year 2022 financial results before the opening of the financial markets on Tuesday, February 28, 2023. Management will host a teleconference at 8:30 a.m.

AdaptHealth Corp. Announces Fourth Quarter and Full Year 2022 Earnings Release Date and Conference Call

An ageing population and increasing chronic illness are key drivers to the HME industry. AHCO's unique platform is set to acquire share in this industry.

AdaptHealth: Helping Stakeholders Adapt To An Ageing Population

PLYMOUTH MEETING, Pa.--( BUSINESS WIRE )--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions, including home medical equipment, medical supplies and related services, today provided its initial guidance for full-year 2023 and preliminary commentary on fourth quarter 2022 results.

AdaptHealth Provides Full-Year 2023 Guidance and Preliminary Commentary on Fourth Quarter 2022 Results

PLYMOUTH MEETING, Pa.--( BUSINESS WIRE )--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that Steve Griggs, CEO, will present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023, at 3:00 pm PT.

AdaptHealth to Participate in JP Morgan Healthcare Conference

PLYMOUTH MEETING, Pa.--( BUSINESS WIRE )--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that Steve Griggs, CEO, Josh Parnes, President, and Jason Clemens, CFO, will participate in a fireside chat at the BofA Securities Home Care Conference on Monday, December 5, at 2:00 pm ET.

AdaptHealth To Participate In BofA Securities Home Care Conference

AdaptHealth Corp. has fundamental momentum growing with supportive technicals. It shows quarterly revenue growth of 16% YoY, which carried down well throughout the AdaptHealth Corp. P&L.

News for AdaptHealth Corp Stock (AHCO)